Gene-environment Interplay Among Modifiable Factors for AD/ADRD: Risk and Resilience Across the Lifespan
Project Number1R01AG089666-01
Contact PI/Project LeaderREYNOLDS, CHANDRA A Other PIs
Awardee OrganizationUNIVERSITY OF COLORADO
Description
Abstract Text
Project Summary/Abstract
The proposed project will leverage 16 twin samples from the Interplay of Genes and Environments across
Studies (IGEMS) Consortium, and incorporate four additional samples, to clarify which modifiable risk factors
may be most influential in increasing risk for Alzheimer’s disease and related dementias (AD/ADRD) and at
which developmental stages their risks are greatest. The overarching goal of this project is to apply twin
models to strengthen or refute causal hypotheses and test gene-environment interplay among modifiable
factors for AD/ADRD, considering risk and resilience profiles within and across developmental periods of the
lifespan. Given the aging of the populations worldwide, AD/ADRD are expected to show substantial increases
over the next few decades, making the proposed study especially timely. We focus on modifiable risk factors in
the hope that clarifying the mechanisms and timing of their effects may help to guide prevention and
intervention to reduce AD/ADRD. Many of our genetically- and environmentally-informed samples include
longitudinal data and polygenic scores (PGS). Drawing from samples in Sweden, Denmark, Australia, and the
United States, we will (a) create multi-dimensional risk scores for early life contexts and (b) evaluate PGSs for
neurodevelopmental disorders and educational attainment in addition to PGSs for Alzheimer’s disease (AD),
AD resilience, and modifiable factors. We will leverage within-between models of twins and siblings of
exposures and genetic risk to test causal hypotheses that control for confounding, and explore gene-
environment (GE) interplay of modifiable risk factors for AD/ADRD and qualities of resilience to address our
aims: (SA1) evaluate mid- and late life physical health and health behavior factors that alter AD/ADRD risk;
(SA2) evaluate midlife and late life socioemotional factors that alter AD/ADRD risk; and (SA3) examine how
early life risks work together with midlife and late life health and socioemotional factors to influence AD/ADRD
risk while also incorporating GE interplay. The proposed research study will extend the life course model of
AD/ADRD by implementing a systems-level approach, guided by the NIH disparities framework, to investigate
key environmental factors that contribute to social inequities, including multiple early life adversities and risk
factors and measuring them at different times. Indeed, we will evaluate how mid- and late life risk act in
combination with early life risks and genetics to create differential profiles of AD/ADRD risk across sex,
cohorts, and countries. Our novel approach of leveraging both twin and genomic data will provide converging
evidence to inform clinical and policy recommendations with regard to the genetic interplay among risk and
protective factors that create differential vulnerabilities for AD/ADRD. The IGEMS Consortium is uniquely
positioned to advance the study aims using powerful approaches, rich phenotypes, high variability across
exposures and socioeconomically diverse samples, and lifespan coverage.
Public Health Relevance Statement
PROJECT NARRATIVE
Alzheimer’s disease and related dementias (AD/ADRD) are predicted to increase substantially, yet how early
life risks work together with midlife and late-life modifiable factors to alter AD/ADRD risk is unclear. The
proposed project will leverage twin and sibling data, with genomic data, to evaluate life course risk and
protective factors for AD/ADRD, testing causal hypotheses and gene-environment interplay. Converging
evidence from our approaches will inform clinical and policy recommendations regarding life course risk and
protective factors that create differential vulnerabilities for AD/ADRD.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAdoptionAgeAgingAlzheimer's DiseaseAlzheimer's disease modelAlzheimer's disease related dementiaAlzheimer's disease riskAnxietyAttention deficit hyperactivity disorderAustraliaBereavementBody mass indexCessation of lifeClinicalCognitionCognitiveCountryDataDenmarkDevelopmentDimensionsDisparityEducationEnvironmentEnvironmental ExposureEnvironmental Risk FactorEtiologyGenesGeneticGenetic RiskGoalsGuide preventionHealthHealth behaviorIndividualInequityInfluentialsInterventionLifeLife Cycle StagesLinkMarital StatusMeasuresMediatingMendelian randomizationMental DepressionMethodsModelingMonozygotic twinsNeurodevelopmental DisorderOutcomePathway interactionsPatternPersonal SatisfactionPharmaceutical PreparationsPhenotypePhysical activityPopulationPositioning AttributeResearchResearch PersonnelRiskRisk FactorsRoleSamplingSchoolsSiblingsSocial EnvironmentSocial isolationSocioeconomic StatusStructureSwedenSystemTestingTwin Multiple BirthUnited StatesUnited States National Institutes of HealthWorkautism spectrum disordercognitive functioncognitive performancecognitive reservecohortdementia riskdepressive symptomsearly life adversityemotional factorfoster caregenomic datahealthy lifestylehigh body mass indexhigh risklate lifelife spanmiddle agemodifiable riskneurodevelopmentnovel strategiesphysical conditioningpolicy recommendationprospectiveprotective factorsresearch studyresiliencesexsocialsocial engagementsocioeconomics
No Sub Projects information available for 1R01AG089666-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01AG089666-01
Patents
No Patents information available for 1R01AG089666-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01AG089666-01
Clinical Studies
No Clinical Studies information available for 1R01AG089666-01
News and More
Related News Releases
No news release information available for 1R01AG089666-01
History
No Historical information available for 1R01AG089666-01
Similar Projects
No Similar Projects information available for 1R01AG089666-01